Federated Hermes’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q2
Sell
-110
Closed -$4K 2308
2018
Q1
$4K Sell
110
-378
-77% -$13.7K ﹤0.01% 2011
2017
Q4
$39K Buy
+488
New +$39K ﹤0.01% 1690